Table 2.
Outcome | Subscales | IPS (n = 132) | Control (n = 120) | Difference (95% CI) |
GAF-S (0–100) | 57.4 (11.90) | 58.3 (10.76) | −1.23 (−3.75 to 1.28) | |
GAF-D (0–100) | 57.6 (11.94) | 56.6 (10.45) | 1.48 (−1.03 to 4.00) | |
PANSS | Positive (7–49) | 12.7 (4.84) | 12.6 (4.40) | 0.028 (−0.928 to 0.983) |
Negative (7–49) | 13.3 (5.13) | 13.5 (5.47) | 0.084 (−0.983 to 1.15) | |
General (16–112) | 29.3 (7.82) | 28.9 (7.87) | 0.455 (−1.11 to 2.02) | |
HADS | Anxiety (0–21) | 6.5 (4.53) | 6.4 (4.30) | −0.221 (−1.07 to 0.632) |
Depression (0–21) | 6.1 (4.24) | 6.2 (4.56) | −0.302 (−1.21 to 0.606) | |
GSDS | Total (0–21) | 8.1 (3.38) | 8.2 (4.11) | −0.289 (−1.1 to 0.487) |
LQoLP | Overall subjective quality of life (1–7) | 4.7 (0.758) | 4.7 (0.861) | 0.032 (−0.137 to 0.201) |
n (%) | n (%) | OR (95% CI) | ||
Hospitalized in final 6 mo | Yes | 11 (8.3) | 22 (18.3) | 2.16 (0.972 to 4.79) |
No | 121 (91.7) | 98 (81.7) | ||
Remission | Yes | 50 (39.7) | 48 (42.1) | 1.23 (0.687 to 2.20) |
No | 76 (60.3) | 66 (57.9) |
Note: Abbreviations are explained in the first footnote to table 1.